Cholesterol composition of erythrocyte membranes and its association with clinical presentation of coronary artery disease

Coronary Artery Disease

Volumn 19, Issue 8, 2008, Pages 583-590

  Tziakas, Dimitrios N ^a,d   Chalikias, Georgios K ^a   Stakos, Dimitrios ^a   Tentes, Ioannis K ^a   Chatzikyriakou, Sofia V ^a   Mitrousi, Konstantina ^a   Kortsaris, Alexandros X ^a   Boudoulas, Harisios ^b   Kaski, Juan Carlos ^c  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d NONE   (Greece)

Author keywords

Cholesterol content; Coronary artery disease; Erythrocyte membranes

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; MEMBRANE LIPID;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL ESTERS; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; ERYTHROCYTE MEMBRANE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 56849112162     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328313819b     Document Type: Article

References (34)

1. Kolodgie FD, Burke AP, Nakazawa G, Cheng Q, Xu X, Virmani R. Free cholesterol in atherosclerotic plaques: where does it come from? Curr Opin Lipidol 2007; 18:500-507.
2. Tabas I. Cholesterol and phospholipid metabolism in macrophages. Biochem Biophys Acta 2000; 1529:164-174.
3. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 2002; 110:905-911.
4. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349:2316-2325.
5. Arbustini E. Total erythrocyte membrane cholesterol. An innocent new marker or an active player in acute coronary syndromes? J Am Coll Cardiol 2007; 49:2090-2092.
6. Yeagle PL. Cholesterol and the cell membrane. Biochim Biophys Acta 1985; 822:267-287.
7. Tziakas D, Kaski JC, Chalikias GK, Romero C, Fredericks S, Tentes IK, et al. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome. J Am Coll Cardiol 2007; 49:2081-2089.
8. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, et al. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27:1341-1381.
9. Thygesen K, Alpert JS, Harvey D; White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007; 28:2525-2538.
10. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al. Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24:28-66.
11. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2007; 28:1598-1660.
12. Braunwald E. Unstable angina: a classification. Circulation 1989; 80:410-414.
13. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20:470-475.
14. Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 2003; 41:37S-42S.
15. Katz SS, Shipley GG, Small DM. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. J Clin Invest 1976; 58:200-211.
16. Rapp JH, Connor WE, Lin DS, Inahara T, Porter JM. Lipids of human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression. J Lipid Res 1983; 24:1329-1335.
17. Felton CV, Crook D, Davies MJ, Oliver MF. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol 1097; 17:1337-1345.
18. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20:1262-1275.
19. Guyton JR, Klemp KF. Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 1996; 16:4-11.
20. Davies MJ. Pathophysiology of acute coronary syndromes. Heart 2000; 83:361-366.
21. Falk E. Why do plaques rupture? Circulation 1992; 86:III30-III42.
22. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25:2054-2061.
23. Lin H-L, Xu X-S, Lu H-X, Zhang L, Li C-J, Tang M-X, et al. Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques. J Mol Cell Cardiol 2007; 43:272-280.
24. Abela GS, Aziz K. Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events: a novel insight into plaque rupture by scanning electron microscopy. Scanning 2006; 28:1-10.
25. Kellner-Weibel G, Yancey PG, Jerome WG, Walser T, Mason RP, Phillips MC, et al. Crystallization of free cholesterol in model macrophage foam cells. Arterioscler Thromb Vasc Biol 1999; 19:1891-1898.
26. Lupu F, Danaricu I and Simionescu N. Development of intracellular lipid deposits in the lipid laden cell of atherosclerotic lesions. A cytochemical and ultrastructural study. Atherosclerosis 1987; 67:127-142.
27. Kellner-Weibel G, Jerome WG, Small DM, Warner JK, Stoltenborg JK, Kearney MA, et al. Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death. Arterioscler Thromb Vasc Biol 1998; 18:423-431.
28. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996; 7:330-335.
29. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999; 142:1-28.
30. London IM, Schwarz H. Erythrocyte metabolism. The metabolic behavior of the cholesterol of human erythrocytes. J Clin Invest 1953; 32:1248-1252.
31. Gold JC, Phillips MC. Effects of membrane lipid composition on the kinetics of cholesterol exchange between lipoproteins and different species of red blood cells. Biochim Biophys Acta 1990; 1027:85-92.
32. Rothblat GH, Arbogast LY, Ray EK. Stimulation of esterified cholesterol accumulation in tissue culture cells exposed to high density lipoproteins enriched in free cholesterol. J Lipid Res 1978; 19:350-358.
33. Gottlieb MH. Rates of cholesterol exchange between human erythrocytes and plasma lipoproteins. Biochim Biophys Acta 1980; 600:530-541.
34. Quarfordt SH, Hilderman HL. Quantitation of the in vitro free cholesterol exchange of human red cells and lipoproteins. J Lipid Res 1970; 11:528-535.